Idioma:

Breast Cancer in Men

Giordano, Sharon H Longo, Dan L ; Longo, Dan L.

The New England journal of medicine, 2018-06, Vol.378 (24), p.2311-2320 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
Breast Cancer in Men
Autor: Giordano, Sharon H
Longo, Dan L ; Longo, Dan L.
Assuntos: Aftercare ; Analysis ; Antineoplastic Agents, Hormonal - adverse effects ; Antineoplastic Agents, Hormonal - therapeutic use ; Aromatase Inhibitors - therapeutic use ; Breast cancer ; Breast Neoplasms, Male - diagnosis ; Breast Neoplasms, Male - drug therapy ; Breast Neoplasms, Male - genetics ; Breast Neoplasms, Male - surgery ; Care and treatment ; Chemotherapy, Adjuvant ; Diagnosis, Differential ; Genes, BRCA1 ; Genes, BRCA2 ; Health aspects ; Health risk assessment ; Hormone replacement therapy ; Humans ; Male ; Men ; Mens health ; Mutation ; Post-menopause ; Prognosis ; Risk Factors ; Tamoxifen - adverse effects ; Tamoxifen - therapeutic use ; Womens health
É parte de: The New England journal of medicine, 2018-06, Vol.378 (24), p.2311-2320
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Descrição: Breast cancer in men accounts for about 1% of all breast cancers and is mainly estrogen-receptor–positive. Few prospective studies of treatment in men have been performed, so management is based largely on extrapolation from results in postmenopausal women.
Editor: United States: Massachusetts Medical Society
Idioma: Inglês

Links

Voltar para lista de resultados